CAR T-cell Therapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Sep 2021| TMR2496A| Transparency

Report Highlights

CAR T-cell Therapy Market – Scope of Report

TMR’s report on the global CAR T-cell therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides revenue of the global CAR T-cell therapy market for the period of 2017–2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global CAR T-cell therapy market from 2021 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the CAR T-cell therapy market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global CAR T-cell therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global CAR T-cell therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global CAR T-cell therapy market.

The report delves into the competitive landscape of the global CAR T-cell therapy market. Key players operating in the global CAR T-cell therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global CAR T-cell therapy market profiled in this report.

Key Questions Answered in CAR T-cell Therapy Market Report

  • What is the sales/revenue generated by CAR T-cell therapy across all regions during the forecast period?
  • What are the opportunities in the global CAR T-cell therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which product type is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
  • What is the market position of different companies operating in the global market?

Frequently Asked Questions (FAQs)

CAR T-cell Therapy Market – Research Objectives and Research Approach

The comprehensive report on the global CAR T-cell therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global CAR T-cell therapy market in terms of product type, indication, end-user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global CAR T-cell therapy market.

  • Table 1 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 2 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
  • Table 3 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 4 : Global Car T-Cell Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 5 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 6 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 7 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
  • Table 8 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 9 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 10 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 11 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
  • Table 12 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 13 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 14 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 15 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
  • Table 16 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 17 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 18 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 19 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
  • Table 20 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 21 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 22 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 23 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by Indication, 2017–2031
  • Table 24 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Figure 1 : Global CAR T-cell Therapy Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global CAR T-cell Therapy Market Value Share, by Product Type, 2020
  • Figure 3 : Global CAR T-cell Therapy Market Value Share, by Indication, 2020
  • Figure 4 : Global CAR T-cell Therapy Market Value Share, by End-user Type, 2020
  • Figure 5 : Global CAR T-cell Therapy Market Value Share, by Region, 2020
  • Figure 6 : Global Car T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 7 : Global Car T-Cell Therapy Market Value (US$ Mn), by Axicabtagene Ciloleucel, 2017–2031
  • Figure 8 : Global Car T-Cell Therapy Market Value (US$ Mn), by Tisagenlecleucel, 2017–2031
  • Figure 9 : Global Car T-Cell Therapy Market Value (US$ Mn), by Brexucabtagene Autoleucel, 2017–2031
  • Figure 10 : Global Car T-Cell Therapy Market Value (US$ Mn), by Lisocabtagene Maraleucel, 2017–2031
  • Figure 11 : Global Car T-Cell Therapy Market Value (US$ Mn), by Idecabtagene Vicleucel, 2017–2031
  • Figure 12 : Global Car T-Cell Therapy Market Value (US$ Mn), by Others, 2017–2031
  • Figure 13 : Global Car T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
  • Figure 14 : Global Car T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 15 : Global Car T-Cell Therapy Market Value (US$ Mn), by Acute Lymphocytic Leukemia, 2017–2031
  • Figure 16 : Global Car T-Cell Therapy Market Value (US$ Mn), by Diffuse Large B-cell Lymphoma, 2017–2031
  • Figure 17 : Global Car T-Cell Therapy Market Value (US$ Mn), by Follicular Lymphoma, 2017–2031
  • Figure 18 : Global Car T-Cell Therapy Market Value (US$ Mn), by Mantle Cell Lymphoma, 2017–2031
  • Figure 19 : Global Car T-Cell Therapy Market Value (US$ Mn), by Multiple Myeloma, 2017–2031
  • Figure 20 : Global Car T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
  • Figure 21 : Global Car T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 22 : Global Car T-Cell Therapy Market Value (US$ Mn), by Hospitals, 2017–2031
  • Figure 23 : Global Car T-Cell Therapy Market Value (US$ Mn), by Cancer Treatment Centers, 2017–2031
  • Figure 24 : Global Car T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 25 : Global Car T-Cell Therapy Market Value Share Analysis, by Region, 2020 and 2031
  • Figure 26 : Global Car T-Cell Therapy Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 27 : North America CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 28 : North America CAR T-Cell Therapy Market Value Share (%), by Country, 2020 and 2031
  • Figure 29 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by Country, 2021–2031
  • Figure 30 : North America CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 31 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
  • Figure 32 : North America CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 33 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
  • Figure 34 : North America CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 35 : North America CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 36 : Europe CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 37 : Europe CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 38 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 39 : Europe CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 40 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
  • Figure 41 : Europe CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 42 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
  • Figure 43 : Europe CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 44 : Europe CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 45 : Asia Pacific CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 46 : Asia Pacific CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 47 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 48 : Asia Pacific CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 49 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
  • Figure 50 : Asia Pacific CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 51 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
  • Figure 52 : Asia Pacific CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 53 : Asia Pacific CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 54 : Latin America CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 55 : Latin America CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 56 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 57 : Latin America CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 58 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
  • Figure 59 : Latin America CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 60 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
  • Figure 61 : Latin America CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 62 : Latin America CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 63 : Middle East & Africa CAR T-Cell Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 64 : Middle East & Africa CAR T-Cell Therapy Market Value Share (%), by Country/Sub-region, 2020 and 2031
  • Figure 65 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
  • Figure 66 : Middle East & Africa CAR T-Cell Therapy Market Value Share Analysis, by Product Type, 2020 and 2031
  • Figure 67 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by Product Type, 2021–2031
  • Figure 68 : Middle East & Africa CAR T-Cell Therapy Market Value Share Analysis, by Indication, 2020 and 2031
  • Figure 69 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by Indication, 2021–2031
  • Figure 70 : Middle East & Africa CAR T-Cell Therapy Market Value Share Analysis, by End-user, 2020 and 2031
  • Figure 71 : Middle East & Africa CAR T-Cell Therapy Market Attractiveness Analysis, by End-user, 2021–2031
  • Figure 72 : Pfizer, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
  • Figure 73 : Pfizer, Inc., Breakdown of Net Sales (%), by Biopharma Segment, 2020
  • Figure 74 : Pfizer, Inc., Breakdown of Net Sales (%) Region/Country, 2020
  • Figure 75 : Pfizer, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
  • Figure 76 : Novartis AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
  • Figure 77 : Novartis AG, Revenue Breakdown of Net Sales (%), by Business Segment, 202
  • Figure 78 : Novartis AG, Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 79 : Novartis AG, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
  • Figure 80 : Bristol-Myers Squibb, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017 –2020
  • Figure 81 : Bristol-Myers Squibb, Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 82 : Bristol-Myers Squibb, R&D Expenses (US$ Mn) 2017–2020
  • Figure 83 : Amgen, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 84 : Amgen, Inc. Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 85 : Amgen, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 86 : Sorrento Therapeutics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 87 : Sorrento Therapeutics, Inc. Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 88 : Sorrento Therapeutics, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 89 : Johnson & Johnson Services, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
  • Figure 90 : Johnson & Johnson Services, Inc., Breakdown of Net Sales (%), by Business Segment (Pharmaceutical), 2020
  • Figure 91 : Johnson & Johnson Services, Inc., Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 92 : Johnson & Johnson Services, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth, 2017–2020
  • Figure 93 : Gilead Sciences, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 94 : Gilead Sciences, Inc., Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 95 : Gilead Sciences, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017-2020
  • Figure 96 : Merck & Co., Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
  • Figure 97 : Merck & Co., Inc., Breakdown of Net Sales (%), by Business Segment, 2020
  • Figure 98 : Merck & Co., Inc., Breakdown of Net Sales (%), by Region/Country, 2020
  • Figure 99 : Merck & Co., Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth, 2017–2020
  • Figure 100 : bluebird bio, Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
  • Figure 101 : bluebird bio, Inc., R&D Expenses (US$ Mn) and Y-o-Y Growth, 2017–2020

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS